Specifically, IR and dyslipidemia trigged by NAFLD are also closely associated with endothelial dysfunction and vasoconstriction by decreasing endothelial nitric oxide production and activating the mitogen-activated protein kinase pathway (39). The gene discussed is WNK2; the disease is metabolic syndrome.